Safety of using genetic engineering biological agents in rheumatoid arthritis

The paper reviews the current trials of the safety of using genetic engineering biological agents (GEBA) in patients with rheumatoid arthritis. It is stated that before its start, GEBA therapy calls for thorough screening of patients to rule out communicable diseases (including tuberculosis) or a hi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: N V Chichasova, E L Nasonov
Format: Artikel
Sprache:Russisch
Veröffentlicht: IMA-PRESS LLC 2010-03-01
Schriftenreihe:Современная ревматология
Schlagworte:
Online-Zugang:https://mrj.ima-press.net/mrj/article/view/272
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!